Hims Stock

Hims is an e-commerce wellness brand made for men with products for skin care, erectile dysfunction, and hair loss. The company works with doctors to prescribe Finasteride and Sildenafil (active ingredient in Viagra) through the app or website. With a telemedicine approach, hims allows customers to get diagnosed and treated at a lower cost and with greater convenience. Hims was incubated at San Francisco-based venture-builder, Atomic. In November 2017, the company raised $7 million in Series A funding from Thrive Capital, Forerunner Ventures, M.C. Ventures, SV Angel, Amity Supply, and Harry’s. In June 2018, hims raised $50 million in Series B funding. Institutional Venture Partners led the round which included Forerunner Ventures, Thrive Capital, Maverick Capital, and Redpoint Ventures. Hims was founded in November 2017 after CEO Andrew Dudum was called out by his sister for having dry skin and breakouts. She ordered him a bunch of expensive products to help fix the issues and Dudum quickly realized that men didn’t have the same options as women when it came to purchasing wellness products. He set out to create a company that offered simple solutions for issues many guys face. In November 2017 hims was launched and nearly four months after it was reported that the company was worth $200 million.